The team of the VOGAS project has visited the project partners in Brazil

From 7 to 16 May, the VOGAS project consortium met in South America, Brazil.

In Manaus and the São Paulo Clinical Center, the team conducted a detailed analysis planning, discussed clinical activities at each center, provided an up-to-date insight into project outcomes, and continued the development of the breath test screening / early detection equipment, started in the VOGAS project.

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824986

Finnish partners have been hosted in Latvia

At the end of March, LU KPMI hosted the partner of the project VOGAS, the senior research scientist of the VTT Technical Research Centre of Finland, Veikko Ikonen. Meanwhile his stay, he visited the Latvian Oncology Centre, as well as met with the medical staff of the LU KPMI. Employees who work with patients on a daily basis presented the clinical activities of the VOGAS project, patient recruitment processes and the conduct of breath tests. V. Ikonen was also introduced with the LU KPMI Biobak and the processes of collection and storage of biological samples of patients. The main ethical aspects of the study, ensuring a safe conduct of the study for patients, were also discussed during the meeting.

In the photo: from left: Veikko Ikonen, the senior research scientist of the VTT Technical Research Centre of Finland; Aija, LU KPMI’s medical nurse; Viktors Veliks, the senior research scientist of LU KMPI

This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824986

On the extension of the VOGAS project activities

The World Health Organization declared the COVID-19 outbreak a Public Health Emergency of International Concern on 30 January 2020 and a pandemic on 11 March. In order to protect the population from possible infection with COVID-19, most countries, included our project partners’ countries, announced the emergency situation, which limited job opportunities in the institutions.

It should be stressed that the COVID-19 pandemic situation significantly affected VOGAS project activities.  The strict restrictions limited the work of all partners and thereby the progress of the research. These pandemic-related problems include delays in purchase/delivery of laboratory consumables and materials caused by the broken supply chains, delays and problems during the transport of samples between laboratories and limited human resources etc.

Considering these reasons project has been extended till September 2022.

The project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824986 

The XXXIV International Workshop of the European Helicobacter and Microbiota Research Group has been held

In response to the global COVID-19 pandemic, the XXXIV International Workshop of the European Helicobacter and Microbiota Research Group was held online.

Among other participating researchers from all over Europe, results of our project were reported by researchers from the University of Innsbruck, Daria Slefarka and Pawel Mochalski. The two researchers who are actively involved in project’s clinical activities, presented a report titled ‘Ex-vivo profiling of volatile organic compounds released from gastric cancer and non-cancerous tissue’.

Abstracts from the event are available here: https://www.microbiotajournal.com/wp-content/uploads/sites/7/2021/09/Book-Abstracts-NEW.pdf

The project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 824986